YOLFTbeta
Guizhou Bailing Group Pharmaceutical Co Ltd

Guizhou Bailing Group Pharmaceutical Co Ltd

002424 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

4.24CNY-0.13 (-2.97%)

Price History

Full chart

Market Stats

Previous Close4.37
Open4.38
Day Range4.23 – 4.38
52-Week Range4.08 – 6.43
Volume8.59M
Market Cap6.50B
P/E (TTM)0.00
Forward P/E38.61
EPS-0.10
Dividend Yield0.00%
Beta0.26
50-Day Avg4.57
200-Day Avg4.65

About

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others. The company offers medicines in various forms, including tablets, tinctures, decoctions, capsules, granules, syrups, powders, pills, dews, pastes, and sprays, as well as wines and honey. Its products are used for cardiovascular, cerebrovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headquartered in Anshun, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Min Niu
  • Employees5.71K
  • HeadquartersNo. 212, Xihang Road, Anshun, China, 561000, China
  • Websitehttps://www.gzbl.com

Leadership

  • Mr. Min NiuGM & Director · b. 1970
  • Mr. Hongxing LiCFO & Accounting Supervisor · b. 1985
  • Mr. Pei ChenDeputy GM & Director · b. 1985
  • Mr. Yuan Zhen YuanExecutive Vice President · b. 1969
  • Mr. Yong JiangDirector · b. 1968

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue446.20M601.49M727.28M863.76M1.14B1.37B1.41B1.57B1.90B2.21B2.59B3.14B2.85B3.09B3.11B3.54B4.26B3.83B3.05B
Growth (%)-+34.80%+20.91%+18.76%+31.80%+20.13%+2.76%+12.05%+20.60%+16.59%+17.05%+21.03%-9.13%+8.32%+0.75%+13.79%+20.42%-10.26%-20.31%
Cost of Revenue229.18M323.77M397.86M412.08M508.34M622.21M560.69M617.41M746.76M794.66M953.81M1.26B1.14B1.35B1.27B1.44B1.95B1.66B1.60B
Gross Profit217.02M277.72M336.65M451.67M630.09M745.37M844.64M957.26M1.15B1.42B1.64B1.87B1.71B1.73B1.84B2.10B2.31B2.17B1.44B
Gross Margin48.64%46.17%46.29%52.29%55.35%54.50%60.10%60.79%60.68%64.11%63.20%59.75%59.83%56.13%59.13%59.39%54.19%56.61%47.38%
Operating Expense121.56M163.46M193.02M252.58M350.20M464.70M524.74M585.73M681.69M849.96M1.01B1.21B1.35B1.54B1.66B1.95B2.79B2.16B1.22B
Operating Income95.46M114.26M143.63M199.10M279.89M280.67M319.90M371.53M470.63M569.59M626.42M664.25M357.82M196.66M174.74M155.65M-484.42M4.35M227.20M
Operating Margin21.39%19.00%19.75%23.05%24.59%20.52%22.76%23.59%24.78%25.72%24.17%21.18%12.55%6.37%5.62%4.40%-11.36%0.11%7.45%
EBITDA108.92M125.22M158.29M210.46M288.36M388.54M425.95M488.68M592.51M676.48M718.90M767.42M503.72M376.84M353.96M364.06M-301.41M251.48M168.44M
EBITDA Margin24.41%20.82%21.76%24.37%25.33%28.41%30.31%31.03%31.20%30.55%27.74%24.46%17.67%12.20%11.38%10.28%-7.07%6.57%5.53%
Net Income71.91M80.30M111.67M158.20M208.38M221.75M269.60M310.48M411.37M482.33M526.14M563.24M282.75M152.38M118.48M138.47M-414.51M33.62M-104.37M
Net Income Margin16.11%13.35%15.35%18.32%18.30%16.21%19.18%19.72%21.66%21.78%20.30%17.96%9.92%4.93%3.81%3.91%-9.72%0.88%-3.42%
R&D---2.45M3.22M6.33M8.62M16.41M21.32M24.47M37.48M30.85M45.44M37.00M30.43M22.40M42.04M24.64M17.96M
R&D as % of Total Revenue---0.28%0.28%0.46%0.61%1.04%1.12%1.11%1.45%0.98%1.59%1.20%0.98%0.63%0.99%0.64%0.59%
Interest Expense8.95M15.19M13.32M26.36M69.03M80.29M51.53M47.60M29.74M21.98M13.28M21.45M59.37M71.59M117.12M101.66M86.85M80.13M3.69M
Interest Expense % of Total Revenue2.01%2.53%1.83%3.05%6.06%5.87%3.67%3.02%1.57%0.99%0.51%0.68%2.08%2.32%3.76%2.87%2.04%2.09%0.12%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets498.55M583.47M819.90M2.80B3.02B3.24B3.48B3.57B3.84B4.24B4.82B5.98B7.05B7.03B6.49B6.89B7.35B7.13B6.20B
Total Liabilities315.87M320.72M445.48M952.49M1.08B1.20B1.35B1.22B1.16B1.17B1.36B2.05B2.91B3.11B2.53B2.90B3.82B3.94B3.02B
Total Equity182.46M262.75M374.42M1.85B1.91B2.02B2.11B2.32B2.65B3.02B3.42B3.87B4.05B3.89B3.94B3.99B3.51B3.18B3.16B
Cash18.44M35.40M205.21M1.32B1.10B940.96M720.32M661.78M960.79M1.22B1.00B545.55M1.14B1.03B465.63M605.02M417.94M395.63M354.80M
Total Debt232.40M217.20M280.60M699.40M765.40M959.40M1.01B751.60M751.60M801.60M861.60M1.58B2.42B2.29B1.74B1.57B1.68B1.50B-
Net Debt213.96M181.80M75.39M-619.54M-333.77M18.44M290.28M89.82M-209.19M-415.79M-138.54M1.04B1.29B1.26B1.28B968.55M1.26B1.11B803.64M

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-79.37M-40.42M125.31M-447.68M201.90M19.52M141.76M395.83M413.23M466.62M79.88M-157.45M467.41M231.78M324.92M502.15M125.77M9.02M748.72M
Investing Cash Flow71.43M88.11M-26.42M-165.69M-325.64M-189.81M-179.13M-59.38M-11.68M-152.28M-215.05M-859.26M-534.50M-204.74M42.59M20.44M-34.83M80.52M-
Financing Cash Flow-68.38M-24.74M54.42M1.74B-96.04M15.87M-183.27M-394.99M-102.55M-57.73M-82.08M562.11M624.21M-411.37M-766.39M-315.28M-214.81M-169.04M-
Capital Expenditure5.68M12.91M21.91M165.69M193.07M180.16M88.74M96.49M121.04M159.34M144.68M129.01M121.91M90.02M425.73M68.45M104.12M42.02M125.24M
Free Cash Flow-85.05M-53.34M103.39M-613.37M8.83M-160.64M53.01M299.34M292.18M307.28M-64.80M-286.46M345.51M141.76M-100.81M433.70M21.65M-33.00M623.47M
Dividends Paid11.50M9.74M9.57M82.74M180.82M157.47M247.56M146.80M137.53M146.60M148.17M157.89M112.90M310.46M100.18M86.55M80.54M81.35M62.48M
FCF to OCF107.15%131.95%82.51%137.01%4.37%-823.12%37.40%75.62%70.71%65.85%-81.12%181.94%73.92%61.16%-31.02%86.37%17.21%-365.80%83.27%
Dividend Paid to FCF-13.52%-18.25%9.26%-13.49%2047.66%-98.02%466.99%49.04%47.07%47.71%-228.65%-55.12%32.68%219.01%-99.38%19.96%372.04%-246.52%10.02%

Earnings

Report DateJun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 19, 2016Oct 25, 2016Feb 26, 2017Apr 20, 2017Aug 27, 2017Oct 24, 2017Mar 27, 2018Apr 24, 2018Aug 22, 2018Oct 24, 2018Dec 31, 2018Apr 23, 2019Aug 27, 2019Oct 24, 2019Apr 23, 2020Aug 21, 2020Oct 28, 2020Apr 27, 2021Aug 30, 2021Oct 29, 2021Apr 23, 2022Aug 27, 2022Oct 27, 2022Apr 26, 2023Aug 25, 2023Oct 27, 2023May 20, 2024Aug 28, 2024Oct 25, 2024May 20, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate----------------------------------------------------------
EPS Actual0.030.030.050.040.030.030.060.040.040.030.060.050.040.030.080.050.040.030.100.070.060.010.130.080.070.070.120.100.070.080.130.110.080.080.130.110.040.060.060.020.04-0.010.010.030.050.010.010.030.020.01-0.400.030.000.020.020.00-0.120.02
Surprise----------------------------------------------------------
Timing------------------------Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market-After-hours--------------Pre-market--Pre-market----

Key Statistics & Ratios

Market Cap6.50B
Enterprise Value7.03B
Trailing P/E0.00
Forward P/E38.61
PEG Ratio0.00
Price / Sales2.54
Price / Book1.93
EPS-0.10
Book Value2.33
Revenue (TTM)2.56B
Gross Profit (TTM)1.05B
EBITDA171.40M
Profit Margin-4.93%
Operating Margin13.02%
Return on Equity-3.94%
Return on Assets0.49%
Shares Outstanding1.39B
Shares Float1.12B
Beta0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20201×
0.22May 29, 2020
20191×
0.08Jun 13, 2019
20181×
0.08Jun 14, 2018
20171×
0.08Apr 19, 2017
20161×
0.08May 10, 2016
20151×
0.07Jun 23, 2015
20141×
0.07Jun 4, 2014
20131×
0.13Mar 29, 2013
20121×
0.07Jul 9, 2012
20111×
0.10Jul 15, 2011
20101×
0.03Oct 29, 2010

Stock Splits

  • Oct 20, 201530:10
  • Jul 15, 201120:10
  • Oct 29, 20101.6:1